Haploidentical, matched-related, and matched-unrelated hematopoietic cell transplant for acute leukemias in the early years of haploidentical transplant implementation in a developing country with a large unrelated donor registry

Only survival bias can explain these findings in CR2+, suggesting some high-risk MUD patients, in which HCT timing is crucial, may not achieve HCT. Alternative donors were associated with higher non-relapse mortality, while PTCy-based Haplo offered the best protection against chronic graft-versus-host disease. Our study suggests Haplo and MUD are acceptable options for patients lacking MSD in developing countries like ours.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-04-15
DOI
https://doi.org/10.3389/fonc.2025.1584631
Citations
1
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
1.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Haploidentical, matched-related, and matched-unrelated hematopoietic cell transplant for acute leukemias in the early years of haploidentical transplant implementation in a developing country with a large unrelated donor registry

Vaneuza Araújo Moreira Funke, Carmem Bonfim, Fernando Barroso Duarte, Mary E.D. Flowers et al.
1 citations
Frontiers in Oncology
Hematopoietic Stem Cell Transplantation
1.77
article

Haploidentical, matched-related, and matched-unrelated hematopoietic cell transplant for acute leukemias in the early years of haploidentical transplant implementation in a developing country with a large unrelated donor registry

Vaneuza Araújo Moreira Funke, Carmem Bonfim, Fernando Barroso Duarte, Mary E.D. Flowers, Jayr Schmidt Filho, Ricardo Chiattone, Rodolfo Daniel de Almeida Soares, Mair Pedro de Souza, Phillip Scheinberg, Mariana Nassif Kerbauy, Anderson João Simione, Shahrukh K. Hashmi, Antônio Vaz de Macedo, Carmen Silvia Vieitas Vergueiro, Gustavo Bettarello, Adriana Seber, Nelson Hamerschlak, Wael Saber, Jinalben Patel, Cláudia Cáceres Astigarraga, Décio Lerner, Leonardo Javier Arcuri, Maria Cristina Martins de Almeida Macedo, Liane Esteves Daudt, Victor Gottardello Zecchin, Marcelo C. Pasquini, Tatiana Dias Marconi Monteiro, Afonso Celso Vigorito, Vergílio R. Colturato, Eduardo Paton, Yana Augusta Novis Zogbi
article en
1 citations

Abstract

Only survival bias can explain these findings in CR2+, suggesting some high-risk MUD patients, in which HCT timing is crucial, may not achieve HCT. Alternative donors were associated with higher non-relapse mortality, while PTCy-based Haplo offered the best protection against chronic graft-versus-host disease. Our study suggests Haplo and MUD are acceptable options for patients lacking MSD in developing countries like ours.

Frontiers in OncologyVol. 15
Medical College of Wisconsin (US), Hospital Israelita Albert Einstein (BR)
Partnerships for the goals
Openalex Percentile: Top 17%
Hematopoietic Stem Cell Transplantation
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.